In particular, SIRT1 activation is likely to be an important mediator for BCH-induced improvement in insulin resistance since SIRT1 inhibitor prevented BCH-induced beneficial effect on hepatic insulin resistance in HF/HFr-fed mice. The gene discussed is SIRT1; the disease is Insulin resistance.